Integrated Diagnostics Holdings plc
(the "Company")
Result of Annual General Meeting
29 May 2024
The Company announces that at the Annual General Meeting ("AGM") held today at the offices of Actis, 2 More London Riverside, London, SE1 2JT, all resolutions contained in the notice of the meeting, including two special resolutions were duly passed. The special resolutions authorise the Company to allot shares on a non-pre-emptive basis and to make market purchases of Equity Securities in the capital of the Company. Each of the resolutions put to the AGM was voted on by way of a poll. The results of the poll for each resolution were as follows:
|
| VOTES FOR | % | VOTES AGAINST | % | VOTES WITHHELD | TOTAL SHARES VOTED |
| 1. To receive and consider the Company's Audited Financial Statements, together with the Reports of the Directors and the Auditor for the year ended 31 December 2023.
| 441,358,887 | 90.74% | 45,062,906 | 9.26% |
0 |
486,421,793 |
| 2. To re-elect Lord Anthony Tudor St John as a Director.
| 459,421,276 | 96.92% | 14,576,146 | 3.08% |
12,424,371 |
486,421,793 |
| 3. To re-elect Dr. Hend El-Sherbini as a Director.
| 486,412,134 | 100.00% | 4,102 | 0.00% |
5,557 |
486,421,793 |
| 4. To elect Sherif El Zeiny as a Director.
| 475,167,144 | 97.69% | 11,249,092 | 2.31% |
5,557 |
486,421,793 |
| 5. To re-elect Richard Henry Phillips as a Director.
| 462,748,330 | 97.63% | 11,249,092 | 2.37% | 12,424,371 | 486,421,793 |
| 6. To re-elect ~Dan Johan Wilmar Olsson as a Director.
| 461,263,507 | 97.31% | 12,733,915 | 2.69% | 12,424,371 | 486,421,793 |
| 7. To re-elect Hussein Hassan Choucri as a Director.
| 462,748,330 | 97.63% | 11,249,092 | 2.37% | 12,424,371 | 486,421,793 |
| 8. To re-elect Yvonne Stillhart as a Director.
| 473,993,320 | 100.00% | 4,102 | 0.00% | 12,424,371 | 486,421,793 |
| 9. To re-appoint PwC LLP as Auditor to hold office from the conclusion of this meeting until the conclusion of the next annual general meeting at which accounts are laid before the Company.
|
486,416,236 | 100.00% | 0 | 0.00% | 5,557 | 486,421,793 |
| 10. To authorise the Directors to determine the Auditor's remuneration.
| 486,421,793 | 100.00% | 0 | 0.00% | 0 | 486,421,793 |
| 11. Authority to issue and allot shares.
| 470,970,353 | 96.82% | 15,451,440 | 3.18% | 0 | 486,421,793 |
| 12. To hold shares as Treasury Shares.
| 486,412,134 | 100.00% | 4,102 | 0.00% | 5,557 | 486,421,793 |
| 13. To execute ancillary documents.
| 486,417,691 | 100.00% | 4,102 | 0.00% | 0 | 486,421,793 |
| 14. To authorise the Directors to dis-apply statutory pre-emption rights.
| 472,455,176 | 97.13% | 13,966,617 | 2.87% | 0 | 486,421,793 |
| 15. Authority for the Company to make market purchases of its own shares.
| 486,421,793 | 100.00% | 0 | 0.00% | 0 | 486,421,793 |
Further information on the resolutions and the voting report will be available on the Company's website at https://investors.idhcorp.com/.
Copies of the resolutions passed as special resolutions at the AGM will shortly be available for inspection at the National Storage Mechanism, which is located at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism.
-Ends-
For further information please contact:
| Integrated Diagnostics Holdings plc |
|
| Tarek Yehia Investor Relations Director | |
|
|
|
| Company Secretary Link Company Matters Limited | |
|
|
|
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.